An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF
Open Access
- 25 February 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 115 (8), 1640-1649
- https://doi.org/10.1182/blood-2009-06-229203
Abstract
In the majority of patients with acquired thrombotic thrombocytopenic purpura (TTP), antibodies are directed toward the spacer domain of ADAMTS13. We have previously shown that region Y658-Y665 is involved. We now show that replacement of R660, Y661, or Y665 with alanine in ADAMTS13 reduced/abolished the binding of 2 previously isolated human monoclonal antibodies and polyclonal antibodies derived from plasma of 6 patients with acquired TTP. We investigated whether these residues also influenced cleavage of short von Willebrand factor (VWF) fragment substrate VWF115. An ADAMTS13 variant (R660A/Y661A/Y665A, ADAMTS13-RYY) showed a 12-fold reduced catalytic efficiency (kcat/Km) arising from greatly reduced (> 25-fold) binding, demonstrated by surface plasmon resonance. The influence of these residue changes on full-length VWF was determined with denaturing and flow assays. ADAMTS13-RYY had reduced activity in both, with proteolysis of VWF unaffected by autoantibody. Binding of ADAMTS13-RYY mutant to VWF was, however, similar to normal. Our results demonstrate that residues within Y658-Y665 of the ADAMTS13 spacer domain that are targeted by autoantibodies in TTP directly interact with a complementary exosite (E1660-R1668) within the VWF A2 domain. Residues R660, Y661, and Y665 are critical for proteolysis of short VWF substrates, but wider domain interactions also make important contributions to cleavage of full-length VWF.Keywords
This publication has 55 references indexed in Scilit:
- Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factorProceedings of the National Academy of Sciences, 2009
- Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factorProceedings of the National Academy of Sciences, 2009
- Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand FactorScience, 2009
- The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formationBlood, 2009
- Pathogenesis of Thrombotic MicroangiopathiesAnnual Review Of Pathology-Mechanisms Of Disease, 2008
- Assembly of Weibel–Palade body-like tubules from N-terminal domains of von Willebrand factorProceedings of the National Academy of Sciences, 2008
- The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flowBlood, 2007
- Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloproteaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factorProceedings of the National Academy of Sciences of the United States of America, 2006
- Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivoJournal of Thrombosis and Haemostasis, 2006